The Organoids And Spheroids Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).
Learn More On The Organoids And Spheroids Market:
https://www.thebusinessresearchcompany.com/report/organoids-and-spheroids-global-market-report
According to The Business Research Company’s Organoids And Spheroids Global Market Report 2024, The organoids and spheroids market size has grown exponentially in recent years. It will grow from $0.93 billion in 2023 to $1.16 billion in 2024 at a compound annual growth rate (CAGR) of 24.4%. The growth in the historic period can be attributed to rapid progress in stem cell research and 3d cell culture technologies, increased funding and investments, rise in chronic diseases, increased use of organoids and spheroids in drug screening and toxicology studies, progress in regenerative medicine and personalized medicine approaches, favorable regulatory frameworks supporting the use of advanced cell culture models in research.
The organoids and spheroids market size is expected to see exponential growth in the next few years. It will grow to $2.78 billion in 2028 at a compound annual growth rate (CAGR) of 24.5%. The growth in the forecast period can be attributed to continued technological advancements, expansion of personalized medicine, enhanced applications in cancer research, ethical and regulatory evolution, growth in commercial products and services based on organoid and spheroid technologies, increased educational initiatives to train researchers in organoid and spheroid technologies. Major trends in the forecast period include integration with advanced technologies, expansion of high-throughput screening methods using organoids for drug discovery, 3D bioprinting and bio fabrication, increasing use of organoids for modeling various cancers, and integration of organoids with microfluidic systems.
The increase in demand for cell therapy and tissue engineering is expected to propel the growth of the organoids and spheroids market going forward. Cell therapy and tissue engineering involve using living cells or engineered tissues to replace, repair, or regenerate damaged tissues and organs in the body. The demand for cell therapy and tissue engineering is rising due to their potential to regenerate damaged tissues and treat previously incurable conditions, offering innovative solutions in regenerative medicine. Organoids and spheroids are utilized in cell therapy and tissue engineering for modeling complex tissues and testing therapeutic approaches in vitro. For instance, in June 2021, according to the Cancer Research Institute, a US-based cancer research organization, approximately 2,073 cellular therapy active agents were added to the pipeline in 2021, marking a 38% increase (572 agents) from the previous year, 2020. Additionally, there were 688 clinical trials for CAR-T therapies and around 398 for other cell therapies in 2021. Therefore, an increase in the demand for cell therapy and tissue engineering will drive the growth of the organoids and spheroids market.
Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=18421&type=smp
1) By Type: Organoids, Spheroids
2) By Method: Extracellular Matrix Scaffold Method, Spinning Bioreactor Method, Hanging Drop Method, Low Adherent Culture Plate Method, Magnetic levitation Method, Other Methods
3) By Application: Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity And Efficacy Testing
4) By End User: Biotechnology And Pharmaceutical Industry, Academic And Research Institutes, Hospitals And Diagnostic Centers
Major companies operating in the organoids and spheroids market are focused on developing advanced solutions, such as 3D primary human hepatocyte (PHH) liver spheroids, to enhance drug discovery and disease modeling. 3D primary human hepatocyte (PHH) liver spheroids refer to clusters of liver cells cultured in three dimensions to more accurately replicate liver function for research and drug testing. For instance, in June 2021, Corning Inc., a US-based technology company, launched HepGo Assay-Ready 3D Liver Spheroid Kits. These kits offer a convenient solution for customers to utilize 3D primary human hepatocyte (PHH) liver spheroids in various applications, including hepatotoxicity assays. It provides pre-formed, assay-ready 3D liver spheroids, eliminating the need for customers to generate the spheroids themselves. This allows for a more efficient and standardized approach to in vitro assays using a 3D liver model.
The organoids and spheroids market report table of contents includes:
1. Executive Summary
2. Organoids And Spheroids Market Characteristics
3. Organoids And Spheroids Market Trends And Strategies
4. Organoids And Spheroids Market – Macro Economic Scenario
5. Global Organoids And Spheroids Market Size and Growth
.
.
.
32. Global Organoids And Spheroids Market Competitive Benchmarking
33. Global Organoids And Spheroids Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Organoids And Spheroids Market
35. Organoids And Spheroids Market Future Outlook and Potential Analysis
36. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
